| # | Security | Value | Shares | % Port | Change | Δ Shares |
|---|---|---|---|---|---|---|
| 1 | ZYMEWORKS INC COM | $575.2M | 22.97M | 24.4% | —HELD | 0 |
| 2 | ANAPTYSBIO INC COM | $437.0M | 7.88M | 18.5% | —HELD | 0 |
| 3 | JAZZ PHARMACEUTICALS PLC SHS USD | $322.6M | 1.71M | 13.7% | —HELD | 0 |
| 4 | CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $238.3M | 6.00M | 10.1% | ADDED | +2.88M |
| 5 | CRINETICS PHARMACEUTICALS IN COM | $155.7M | 4.29M | 6.6% | —HELD | 0 |
| 6 | AKTIS ONCOLOGY INC COM ADDED | $86.3M | 4.82M | 3.7% | NEW | — |
| 7 | ORIC PHARMACEUTICALS INC COM | $85.2M | 6.73M | 3.6% | —HELD | 0 |
| 8 | CG ONCOLOGY INC COM | $74.6M | 1.10M | 3.2% | ADDED | +809.2K |
| 9 | CRISPR THERAPEUTICS AG NAMEN AKT | $66.1M | 1.39M | 2.8% | —HELD | 0 |
| 10 | ETON PHARMACEUTICALS INC COM | $53.6M | 2.17M | 2.3% | ADDED | +141.4K |
| 11 | GALAPAGOS NV SPON ADR | $50.0M | 1.67M | 2.1% | —HELD | 0 |
| 12 | XENCOR INC COM | $26.3M | 2.18M | 1.1% | ADDED | +2.12M |
| 13 | NEUROGENE INC COM | $25.6M | 1.27M | 1.1% | —HELD | 0 |
| 14 | BRIDGEBIO ONCOLOGY THERAPEUT COM NEW | $25.3M | 2.82M | 1.1% | —HELD | 0 |
| 15 | MBX BIOSCIENCES INC COM | $23.2M | 777.0K | 1.0% | REDUCED | -1,346,604 |
| 16 | RELAY THERAPEUTICS INC COM | $19.0M | 1.90M | 0.8% | NEW | — |
| 17 | CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $16.3M | 410.8K | 0.7% | REDUCED | -2,704,200 |
| 18 | ZENAS BIOPHARMA INC COM | $15.4M | 789.5K | 0.7% | —HELD | 0 |
| 19 | ERASCA INC COM | $14.6M | 900.0K | 0.6% | NEW | — |
| 20 | EIKON THERAPEUTICS INC COM ADDED | $7.8M | 732.6K | 0.3% | NEW | — |
| 21 | REPLIMUNE GROUP INC COM | $7.7M | 1.00M | 0.3% | NEW | — |
| 22 | ZURA BIO LTD CLASS A ORD SHS | $7.0M | 1.18M | 0.3% | NEW | — |
| 23 | PHATHOM PHARMACEUTICALS INC COM | $6.9M | 625.0K | 0.3% | NEW | — |
| 24 | MEREO BIOPHARMA GROUP PLC SPON ADS | $4.4M | 13.37M | 0.2% | ADDED | +5.51M |
| 25 | STOKE THERAPEUTICS INC COM | $3.3M | 100.0K | 0.1% | NEW | — |
Holdings data sourced from SEC EDGAR 13F-HR filings. Updated quarterly, approximately 45 days after quarter end. All data is public domain.
Last filed: May 15, 2026